NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE241489 Query DataSets for GSE241489
Status Public on Feb 07, 2024
Title Relative quantification of the recA gene for antibiotic susceptibility testing in response to ciprofloxacin for pathogens of concern
Organisms Yersinia pestis; Bacillus anthracis
Experiment type Expression profiling by high throughput sequencing
Summary Antibiotic resistance (AR) is one of the greatest threats to global health and is associated with higher treatment costs, longer hospital stays, and increased mortality. Current gold standard antibiotic susceptibility tests (AST) are dependent on organism growth rates resulting in prolonged diagnostic answers for slow growing organisms. Changes in the cellular transcriptome can be instantaneous in the presence of stressors such as antibiotic pressure. Here, we demonstrate that relative quantification of the recA gene in response to breakpoint concentrations of ciprofloxacin is an indicator of pathogen susceptibly. For this purpose, we developed seven duplex RT-qPCR assays targeting the recA and 16S rRNA gene, as response and housekeeping genes respectively, for biothreat and ESKAPE pathogens. Surrogate biothreat agents Y. pestis and B. anthracis saw increases in relative recA gene expression, independent of growth rate after 15 minutes of exposure to ciprofloxacin with maximal expression seen after 60 minutes. Treatment with doxycycline also demonstrated an increase in relative recA fold changes compared to no treatment controls. Final evaluation of all seven duplex assays tested across 125 strains, including Tier 1 pathogens, from broth culture demonstrated an overall categorical agreement compared to gold standard microbroth dilution of 97.56% with major error (ME) rates of 1.59% and very major error (VME) rates of 3.23%. Testing on pathogen strains commonly associated with urinary tract infections in contrived clinical sample sets demonstrated an overall categorical agreement of 95.8% with a ME rate of 0.0% and VME rate of 7.69%. These data indicate that relative quantification of a single highly conserved gene accurately predicts susceptibility for multiple bacterial species in response to ciprofloxacin.
 
Overall design RNA sequencing was performed on bacterial samples exposed to breakpoint concentrations of ciprofloxacin across time. RNA sequencing analysis was compared between resistant and suceptable strains as well as compared across multple organisms including B. anthracis and Y. pestis.
 
Contributor(s) Stefan CP
Citation(s) 38302590
Submission date Aug 22, 2023
Last update date Feb 07, 2024
Contact name Christopher Patrick Stefan
E-mail(s) christopher.p.stefan.civ@health.mil
Organization name USAMRIID
Street address 1425 Porter Street
City Frederick
State/province MD
ZIP/Postal code 21702
Country USA
 
Platforms (2)
GPL29781 Illumina MiSeq (Bacillus anthracis)
GPL33703 Illumina MiSeq (Yersinia pestis)
Samples (48)
GSM7729807 BACI355, Suceptable, Time 0 minutes, Replicate A
GSM7729808 BACI355, Suceptable, Time 0 minutes, Replicate B
GSM7729809 BACI355, Suceptable, Time 0 minutes, Replicate C
Relations
BioProject PRJNA1008259

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE241489_BACI355_Counts.xlsx 656.6 Kb (ftp)(http) XLSX
GSE241489_BACI358_Counts.xlsx 648.8 Kb (ftp)(http) XLSX
GSE241489_YERS052_Counts.xlsx 448.4 Kb (ftp)(http) XLSX
GSE241489_YERS053_Counts.xlsx 472.7 Kb (ftp)(http) XLSX
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap